How to cite this WIREs title:
WIREs Syst Biol Med

Impact Factor: 4.192

Sox2 and Oct‐3/4: a versatile pair of master regulators that orchestrate the self‐renewal and pluripotency of embryonic stem cells

Focus Article

Angie Rizzino

Published Online: Sep 22 2009

DOI: 10.1002/wsbm.12

Full article on Wiley Online Library: HTML PDF

Can't access this content? Tell your librarian.

Abstract During the past 10 years, remarkable progress has been made in understanding the transcriptional mechanisms that control the biology of stem cells. Given the importance of stem cells in development, regenerative medicine, and cancer, it is no surprise that the pace of discovery continues to accelerate—paradigm‐shifting models proposed only a few years ago are quickly giving way to even more sophisticated models of regulation. This review summarizes some of the major advances made in delineating the roles of two transcription factors, Sox2 and Oct‐3/4, in stem cell biology. Additionally, unanswered questions related to their mechanisms of action are discussed. When viewed together, it is evident that Sox2 and Oct‐3/4 exhibit the major properties expected of master regulators. They are each essential for mammalian development, they help regulate the transcription of other genes that are essential for development, and they influence their own transcription by both positive and negative feedback loops. Moreover, small changes in the levels of either Sox2 or Oct‐3/4 trigger the differentiation of embryonic stem (ES) cells. Thus, each functions as a molecular rheostat to control the self‐renewal and pluripotency of ES cells. Overall, understanding how Sox2 and Oct‐3/4 function mechanistically will not only provide important insights into stem cells in general, but should also have a significant impact on our understanding of induced pluripotent stem (iPS) cells and, hence, the emerging field of regenerative medicine. Copyright © 2009 John Wiley & Sons, Inc. This article is categorized under: Developmental Biology > Stem Cell Biology and Regeneration

This WIREs title offers downloadable PowerPoint presentations of figures for non-profit, educational use, provided the content is not modified and full credit is given to the author and publication.

Download a PowerPoint presentation of all images

An expanded model for the regulation of Oct‐3/4:Sox2 target genes. Sox2 and Oct‐3/4 work together cooperatively to regulate their own transcription and the transcription of a large set of downstream target genes. This includes genes expressed in ES cells and those not expressed in ES cells.

[ Normal View | Magnified View ]

Consensus sequence for HMG/POU cassettes. A consensus sequence for HMG/POU cassettes derived by comparing the HMG/POU sequences of six Oct‐3/4:Sox2 target genes (FGF‐4, Sox2, Oct‐3/4, Nanog, Fbx15, and UTF1). The triangle represents possible inserts of up to three base pairs between the HMG and POU motifs. For example, the FGF‐4 gene contains a three‐base‐pair insert between its HMG and POU motifs. For the remaining five genes, as well as their HMG and POU motifs, are directly adjacent to one another.

[ Normal View | Magnified View ]

Sox2: Oct‐3/4 partnership. Sox2 and Oct‐3/4 work together cooperatively to regulate their own transcription and the transcription of a large set of downstream target genes in EC and ES cells.

[ Normal View | Magnified View ]

Oct‐3/4 and Sox2 function as molecular rheostats. Increasing or decreasing the levels of either Sox2 or Oct‐3/4 in ES cells promotes their differentiation. However, the spectra of cell types that form vary. The cell types formed were determined by markers expressed in the differentiated cell populations. TE, trophectoderm; Endo, endoderm; Meso, mesoderm; ECTO, ectoderm.

[ Normal View | Magnified View ]

Elevating the expression of Sox2 reducing the expression of genes required for the self‐renewal of ES cells. Elevating the levels of Sox2 in EC and ES cells reduces the expression of the Oct‐3/4 gene and the expression of downstream Sox: Oct target genes, such as FGF‐4, Nanog, and UTF1. As indicated by the dotted lines, it is unclear whether Oct‐3/4 continues to positively influence the expression of Oct‐3/4 : Sox2 target genes when Sox2 is overexpressed.

[ Normal View | Magnified View ]

Sox protein redundancy and the regulation of Oct‐3/4 : Sox target genes. Oct‐3/4 is proposed to work in conjunction with Sox2, as well as Sox4, Sox11, and Sox15, in ES cells to regulate the transcription of the Oct‐3/4 and Sox2 genes as well as the transcription of a large set of downstream target genes. Sox2 is also proposed to indirectly regulate the transcription of the Oct‐3/4 gene by upregulating Nr5a2 and downregulating Nr2f2, which are positive and negative regulators of the Oct‐3/4 gene, respectively. As indicated by the dotted lines, it remains to be determined whether Sox4, Sox11, or Sox15 influence the expression of the Oct‐3/4 and Sox2 genes.

[ Normal View | Magnified View ]

References

Schöler, HR, Ruppert, S, Suzuki, N, Chowdhury, K, Gruss, P. New type of POU domain in germ line‐specific protein Oct‐4. Nature 1990, 344(6265): 435–439.
Niwa, H. Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struct Funct 2001, 26(3): 137–148.
Hu, T, Liu, S, Breiter, DR, Wang, F, Tang, Y, et al. Octamer 4 small interfering RNA results in cancer stem cell‐like cell apoptosis. Cancer Res 2008, 68(16): 6533–6540.
Takahashi, K, Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4): 663–676.
Yu, J, Vodyanik, MA, Smuga‐Otto, K, Antosiewicz‐Bourget, J, Frane, JL, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318(5858): 1917–1920.
Nakagawa, M, Koyanagi, M, Tanabe, K, Takahashi, K, Ichisaka, T, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2007, 26(1): 101–106.
Huangfu, D, Maehr, R, Guo, W, Eijkelenboom, A, Snitow, M, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small‐molecule compounds. Nat Biotechnolol. 2008, 26(7): 795–797.
Mali, P, Zhaohui, Y, Hommond, HH, Yu, X, Lin, J, et al. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 2008, 26: 1998–2005.
Eminli, S, Utikal, JS, Arnold, K, Jaenisch, R, Hochedlinger, K. Reprogramming of neural progenitor cells into iPS cells in the absence of exogenous Sox2 expression. Stem Cells 2008, 26(10): 2467–2474.
Kim, JB, Zaehres, H, Wu, G, Gentile, L, Ko, K, et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008, 454(7204): 646–650.
Kiefer, JC. Back to basics: Sox genes. Dev Dynamics 2007, 236(8): 2356–2366.
Nichols, J, Zevnik, B, Anastassiadis, K, Niwa, H, Klewe‐Nebenius, D, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998, 95(3): 379–391.
Avilion, AA, Nicolis, SK, Pevny, LH, Perez, L, Vivian, N et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003, 17(1): 126–140, PMCID: PMC195970.
Niwa, H, Miyazaki, J, Smith, AG. Quantitative expression of Oct‐3/4 defines differentiation, dedifferentiation or self‐renewal of ES cells. Nat Genet 2000, 24(4): 328–330.
Chew, JL, Loh, YH, Zhang, W, Chen, X, Tam, WL, et al. Reciprocal transcriptional regulation of Pou5f1 and Sox 2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 2005, 25(14): 6031–6046, PMCID: PMC1168830.
Chen, Y, Shi, L, Zhang, L, Li, R, Liang, J, et al. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 2008, 283(26): 17969–17978.
Otsubo, T, Akiyama, Y, Yanagihara, K, Yuasa, Y. SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell‐cycle arrest and apoptosis. Br J Cancer 2008, 98(4): 824–831.
Reményi, A, Lins, K, Nissen, LJ, Reinbold, R, Schöler, HR, et al. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev 2003, 17(16): 2048–2059.
Williams, DC Jr, Cai, M, Clore, GM. Molecular basis for synergistic transcriptional activation by Oct1 and Sox2 revealed from the solution structure of the 42‐kDa Oct1.Sox2.Hoxb1‐DNA ternary transcription factor complex. J Biol Chem 2004, 279(2): 1449–1457.
Boiani, M, Schöler, HR. Regulatory networks in embryo‐derived pluripotent stem cells. Nat Rev Mol Cell Biol 2005, 6(11): 872–884.
Pan, G, Thomson, JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 2007, 17(1): 42–49.
Sharov, AA, Ko, MSH. Human ES cell profiling broadens the reach of bivalent domains. Cell Stem Cell 2007, 1(3): 237–238.
Lorincz, MC, Schübeler, D. RNA polymerase II: just stopping by. Cell 2007, 130(1): 16–18.
Jaenisch, R, Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008, 132(4): 567–582.
Curatola, AM, Basilico, C. Expression of the K‐fgf proto‐oncogene is controlled by 3′ regulatory elements which are specific for embryonic carcinoma cells. Mol Cell Biol 1990, 10(6): 2475–2484, PMCID: PMC360604.
Ma, Y‐G, Rosfjord, E, Huebert, C, Wilder, P, Tiesman, J, et al. Transcriptional regulation of the murine k‐FGF gene in embryonic cell lines. Dev Biol 1992, 154(1): 45–54.
Yuan, H, Corbi, N, Basilico, C, Dailey, L. Developmental‐specific activity of the FGF‐4 enhancer requires the synergistic action of Sox2 and Oct‐3. Genes Dev 1995, 9(21): 2635–2645.
Boer, B, Bernadt, CT, Desler, M, Wilder, PJ, Kopp, JL, et al. Differential activity of the FGF‐4 enhancer in F9 and P19 embryonal carcinoma cells. J Cell Physiol 2006, 208(1): 97–108.
Nowling, TK, Johnson, LR, Wiebe, MS, Rizzino, A. Identification of the transactivation domain of the transcription factor Sox‐2 and an associated co‐activator. J. Biol Chem 2000, 275(6): 3810–3818.
Fraidenraich, D, Lang, R, Basilico, C. Distinct regulatory elements govern Fgf4 gene expression in the mouse blastocyst, myotomes, and developing limb. Dev Biol 1998, 204(1): 197–209.
Ambrosetti, D‐C, Schöler, HR, Dailey, L, Basilico, C. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct‐3 on the Fibroblast Growth Factor‐4 enhancer. J Biol Chem 2000, 275(30): 23387–23397.
Nowling, T, Bernadt, C, Johnson, L, Desler, M, Rizzino, A. The Co‐activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF‐4 gene. J Biol Chem 2003, 278(16): 13696–13705.
Masui,, S, Nakatake,, Y, Toyooka,, Y, Shimosato,, D, Yagi,, R, et al. Nat Cell Biol 2007, 9(6): 625–635.
Tomioka, M, Nishimoto, M, Miyagi, S, Katayanagi, T, Fukui, N, et al. Identification of Sox‐2 regulatory region which is under the control of Oct‐3/4‐Sox‐2 complex. Nucleic Acids Res 2002, 30(14): 3202–3213.
Okumura‐Nakanishi, S, Saito, M, Niwa, H, Ishikawa, F. Oct‐3/4 and Sox2 regulate Oct‐3/4 gene in embryonic stem cells. J Biol Chem 2005, 280(7): 5307–5317.
Mallanna, SK, Boer, B, Desler, M, Rizzino, A. Differential regulation of the Oct‐3/4 gene in cell culture model systems that parallel different stages of mammalian development. Mol Reprod Dev 2008, 75(8): 1247–1257.
Boyer, LA, Lee, TI, Cole, MF, Johnstone, SE, Levine, SS, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122(6): 947–956.
Loh, Y‐H, Wu, Q, Chew, J‐L, Vega, VB, Zhang, W, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006, 38: 431–440.
Chen, X, Xu, H, Yuan, P, Fang, F, Huss, M, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133(6): 1106–1117.
Chakravarthy, H, Boer, B, Desler, M, Mallanna, SK, McKeithan, TW, et al. Identification of DPPA4 and other genes as putative Sox2:Oct‐3/4 target genes using a combination of in silico analysis and transcription‐based assays. J Cell Physiol 2008, 216(3): 651–662.
Lee, TI, Jenner, RG, Boyer, LA, Guenther, MG, Levine, SS, et al. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 2006, 125(2): 301–313.
Boyer, LA, Plath, K, Zeitlinger, J, Brambrink, T, Medeiros, LA, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006, 441: 349–353.
Wiebe, MS, Nowling, TK, Rizzino, A. Identification of novel domains within Sox‐2 and Sox‐11 involved in autoinhibition of DNA binding and partnership specificity. J Biol Chem 2003, 278(20): 17901–17911.
Maruyama, M, Ichisaka, T, Nakagawa, M, Yamanaka, S. Differential roles for Sox15 and Sox2 in transcriptional control in mouse embryonic stem cells. J Biol Chem 2005, 280(26): 24371–24379.
Schilham, MW, Oosterwegel, MA, Moerer, P, Ya, J, de Boer, PA, et al. Defects in cardiac outflow tract formation and pro‐B‐lymphocyte expansion in mice lacking Sox‐4. Nature 1996, 380(6576): 711–714.
Sock, E, Rettig, SD, Enderich, J, Bösl, MR, Tamm, ER, et al. Gene targeting reveals a widespread role for the high‐mobility‐group transcription factor Sox11 in tissue remodeling. Mol Cell Biol 2004, 24(15): 6635–6644.
Bernadt, CT, Nowling, T, Rizzino, A. Transcription factor Sox‐2 inhibits Co‐activator stimulated transcription. Mol Reprod Dev 2004, 69(3): 260–267.
Boer, B, Kopp, J, Mallanna, S, Desler, M, Chakravarthy, H, et al. Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct‐3/4 target genes. Nucleic Acids Res 2007, 35(6): 1773–1786.
Pan, G, Li, J, Zhou, Y, Zheng, H, Pei, D. A negative feedback loop of transcription factors that controls stem cell pluripotency and self‐renewal. FASEB J 2006, 20(10): 1730–1732.
Kopp, JL, Ormsbee, BD, Desler, M, Rizzino, A. Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 2008, 26(4): 903–911.
Niwa, H, Toyooka, Y, Shimosato, D, Strumpf, D, Takahashi, K, et al. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 2005, 123(5): 917–929.
Hay, DC, Sutherland, L, Clark, J, Burdon, T. Oct‐4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 2004, 22(2): 225–235.
Liang, J, Wan, M, Zhang, Y, Gu, P, Xin, H, et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol 2008, 10(6): 731–739.
Wang, J, Rao, S, Chu, J, Shen, X, Levasseur, DN, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006, 444(7117): 364–368.

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts